KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio (2017 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Interest Coverage Ratio for 17 consecutive years, with 49.84 as the latest value for Q1 2026.

  • For Q1 2026, Interest Coverage Ratio fell 26.72% year-over-year to 49.84; the TTM value through Mar 2026 reached 75.61, down 5.66%, while the annual FY2025 figure was 81.69, 12.99% up from the prior year.
  • Interest Coverage Ratio hit 49.84 in Q1 2026 for Regeneron Pharmaceuticals, down from 72.12 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 299.86 in Q2 2025 and bottomed at 46.67 in Q1 2024.
  • Average Interest Coverage Ratio over 5 years is 81.58, with a median of 68.01 recorded in 2025.
  • Year-over-year, Interest Coverage Ratio tumbled 64.8% in 2022 and then surged 314.92% in 2025.
  • Regeneron Pharmaceuticals' Interest Coverage Ratio stood at 65.91 in 2022, then dropped by 19.34% to 53.16 in 2023, then soared by 77.38% to 94.3 in 2024, then dropped by 23.52% to 72.12 in 2025, then plummeted by 30.9% to 49.84 in 2026.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 49.84, 72.12, and 53.2 for Q1 2026, Q4 2025, and Q3 2025 respectively.